MOSCOW, June 25. /TASS/ — the Domestic drug, “Replevin” company “Promomed”, which is similar to that invented in Japan drug “Favipiravir”, is used to treat novel coronavirus infection, received approval of the Ministry of health.
this information was published on the website of the state registry of medicines.
“trade name of the drug “Replevin”. Or modified international nonproprietary or chemical name, the “Favipiravir”. Release form — tablets film-coated. The registration date is 23 June 2020,” — said on the website.
Previously the Executive Director of JSC “Biochemist” Dmitry Zemskov explained TASS that “Replevin” blocks the replication of the virus in human cells, thus preventing the spread of infection in the body.
the Drug has efficacy against RNA viruses which belongs to the coronavirus COVID-19. In applying the drug significantly reduced the time of infection in the body — almost up to 4 days.
the First was in Russia a preparation on the basis of favipiravir was “Aviewer” produced by the Russian direct investment Fund and the group of companies “Chemrar”.
